SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-039067
Filing Date
2023-02-14
Accepted
2023-02-14 16:07:12
Documents
1
Group Members
ROBERT I. TEPPERTHIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES GP IV, L.P.THIRD ROCK VENTURES IV, L.P.TRV GP III, LLCTRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d442890dsc13ga.htm SC 13G/A 152177
  Complete submission text file 0001193125-23-039067.txt   153868
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures III, L.P. (Filed by) CIK: 0001569705 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Subject) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91080 | Film No.: 23629062
SIC: 2834 Pharmaceutical Preparations